The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism

Background: Secondary hyperparathyroidism (SHPT) is associated with high incidences of cardiovascular disease, bone fracture, and mortality. This study was conducted to demonstrate the effectiveness of cinacalcet treatment on chronic kidney disease-mineral bone disorder (CKD-MBD) markers in chronic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Renal failure 2019-01, Vol.41 (1), p.326-333
Hauptverfasser:	Susantitaphong, Paweena, Vadcharavivad, Somratai, Susomboon, Teerada, Singhan, Wanchana, Dumrongpisutikul, Netsiri, Jakchairoongruang, Ketsuda, Eiam-Ong, Somchai, Praditpornsilpa, Kearkiat
Format:	Artikel
Sprache:	eng
Schlagworte:	Acid phosphatase (tartrate-resistant) Bone diseases Calcification Calcification (ectopic) Cardiovascular diseases chronic hemodialysis Cinacalcet Clinical Study Fibroblast growth factor 23 Hemodialysis Hyperparathyroidism Kidney diseases Minerals Parathyroid Parathyroid hormone Parathyroidectomy Patients severe secondary hyperparathyroidism Surgery Vitamin D
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!